Selecta Biosciences

Selecta Biosciences

Pioneering RNA cell therapy for autoimmune disease.

  • Edit
Get premium to view all results
DateInvestorsAmountRound
-investor investor investor

€0.0

round
investor investor

€0.0

round
investor investor investor investor

€0.0

round
investor investor investor investor

€0.0

round
investor

€0.0

round
investor

€0.0

round
N/A

€0.0

round
N/A

€0.0

round
N/A

€0.0

round
N/A

€0.0

round
investor investor investor investor investor

€0.0

round
N/A

€0.0

round
N/A

€0.0

round
investor

€0.0

round
N/A

€0.0

round
N/A

€0.0

round
N/A

€0.0

round
N/A

€0.0

round
*

N/A

Acquisition
Total Funding000k

Financials

Estimates*

Get premium to view all results
Edit
Revenues, earnings & profits over time
USD2018201920202021202220232024
Revenues0000000000000000000000000000
% growth336 %639 %149 %413 %30 %(77 %)50 %
EBITDA0000000000000000000000000000
% EBITDA margin(6962 %)(805 %)(342 %)(5 %)15 %-(110 %)
Profit0000000000000000000000000000
% profit margin(7235 %)(829 %)(415 %)(30 %)32 %(845 %)(199 %)
EV0000000000000000000000000000
EV / revenue00.0x00.0x00.0x00.0x00.0x00.0x00.0x
EV / EBITDA00.0x00.0x00.0x00.0x00.0x00.0x00.0x
R&D budget0000000000000000000000000000
R&D % of revenue5281 %640 %328 %81 %65 %--

Source: Company filings or news article

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo

Investments by Selecta Biosciences

Edit